Bridgebio
Founded 2014 · 1,034 employees on LinkedIn · 9 known investors
Find your way into Bridgebio
Sign up to see every warm intro you have to Bridgebio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bridgebio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Founders & leadership
Investors · 9
How we know: Aisling Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: HEALTHCARE ROYALTY PARTNERS's portfolio page · Not right? Tell us
How we know: Longwood Fund's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sequoia Capital's portfolio page · Not right? Tell us
Founder mafia
5 people who came through Bridgebio went on to found or lead other companies.
Frequently asked questions
- What does Bridgebio do?
- BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
- Who are Bridgebio's investors?
- Bridgebio's investors include Aisling Capital, Amzak Health, EcoR1 Capital, Frazier Life Sciences, HEALTHCARE ROYALTY PARTNERS, Longwood Fund, Sequoia Capital, Viking Global and 1 more.







